Administration of Inactivated Influenza Vaccine

Size: px
Start display at page:

Download "Administration of Inactivated Influenza Vaccine"

Transcription

1 Policy Number LCH-109 This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational change this FRONT COVER has been added so the reader is aware of any changes to their role or to terminology which has now been superseded. When reading this document please take account of the changes highlighted in Part B and C of this form. Part A Information about this Document Policy Name Administration of Inactivated Influenza Vaccine Policy Type Board Approved (Trust-wide) Trust-wide Divisional / Team / Locality Action No Change Minor Change Major Change New Policy No Longer Needed Approval As Mersey Care s Executive Director / Lead for this document, I confirm that this document: a) complies with the latest statutory / regulatory requirements, b) complies with the latest national guidance, c) has been updated to reflect the requirements of clinicians and officers, and d) has been updated to reflect any local contractual requirements Signature: Date: Part B Changes in Terminology (used with Minor Change, Major Changes & New Policy only) Terminology used in this Document New terminology when reading this Document Part C Additional Information Added (to be used with Major Changes only) Section / Paragraph No Outline of the information that has been added to this document especially where it may change what staff need to do Part D Rationale (to be used with New Policy & Policy No Longer Required only) Please explain why this new document needs to be adopted or why this document is no longer required Part E Oversight Arrangements (to be used with New Policy only) Accountable Director Recommending Committee

2 Approving Committee Next Review Date LCH Policy Alignment Process Form 1

3 SUPPORTING STATEMENTS This document should be read in conjunction with the following statements: SAFEGUARDING IS EVERYBODY S BUSINESS All Mersey Care NHS Foundation Trust employees have a statutory duty to safeguard and promote the welfare of children and adults, including: being alert to the possibility of child / adult abuse and neglect through their observation of abuse, or by professional judgement made as a result of information gathered about the child / adult; knowing how to deal with a disclosure or allegation of child / adult abuse; undertaking training as appropriate for their role and keeping themselves updated; being aware of and following the local policies and procedures they need to follow if they have a child / adult concern; ensuring appropriate advice and support is accessed either from managers, Safeguarding Ambassadors or the trust s safeguarding team; participating in multi-agency working to safeguard the child or adult (if appropriate to your role); ensuring contemporaneous records are kept at all times and record keeping is in strict adherence to Mersey Care NHS Foundation Trust policy and procedures and professional guidelines. Roles, responsibilities and accountabilities, will differ depending on the post you hold within the organisation; ensuring that all staff and their managers discuss and record any safeguarding issues that arise at each supervision session EQUALITY AND HUMAN RIGHTS Mersey Care NHS Foundation Trust recognises that some sections of society experience prejudice and discrimination. The Equality Act 2010 specifically recognises the protected characteristics of age, disability, gender, race, religion or belief, sexual orientation and transgender. The Equality Act also requires regard to socio-economic factors including pregnancy /maternity and marriage/civil partnership. The trust is committed to equality of opportunity and anti-discriminatory practice both in the provision of services and in our role as a major employer. The trust believes that all people have the right to be treated with dignity and respect and is committed to the elimination of unfair and unlawful discriminatory practices. Mersey Care NHS Foundation Trust also is aware of its legal duties under the Human Rights Act Section 6 of the Human Rights Act requires all public authorities to uphold and promote Human Rights in everything they do. It is unlawful for a public authority to perform any act which contravenes the Human Rights Act. Mersey Care NHS Foundation Trust is committed to carrying out its functions and service delivery in line the with a Human Rights based approach and the FREDA principles of Fairness, Respect, Equality Dignity, and Autonomy

4 Title Protocol reference number Aim and purpose of protocol Author Protocol on the Administration of Inactivated Influenza Vaccine to Adults by Health Care Assistants (HCAs) and other Health Care Support Workers (HCSWs) 109 To enable suitably trained Health Care Assistants (HCAs) and other Health Care Support Workers (HCSWs) working for or on behalf of Liverpool Community Health who have undertaken relevant training, to administer Influenza vaccine to adults. Vaccination and Immunisation Lead Nurse Type New Policy Reviewed Policy Review date OCTOBER 2018 Person/group accountable for review Type of evidence base used Immunisation Lead Nurse C: Evidence which includes published and/or unpublished studies and expert opinion (limited scientific evidence) ISSUE DATE NOVEMBER 2016 Authorised by Clinical Standards Group 25 th October 2016 Equality Analysis Undertaken Yes Evidence collated Yes No No

5 Version Control Form Version Number: 5 Ratified by: Clinical Standards Group Date of Approval: 25 th October 2016 Name of originator/author: Approving Body / Committee: Immunisation Lead Nurse Clinical Standards Group Date issued: November 2016 Review date: October 2018 Target audience: Name of Lead Director / Managing Director: Health Care Assistants (HCAs) and other Health Care Support Workers (HCSWs) working for or on behalf of Liverpool Community Health who have undertaken relevant training, to administer influenza vaccine to adults aged 16 years and over Director of Nursing Changes / Alterations Made To Previous Version: Refresh of hyperlinks and removal of old Removal of audit tool in appendix Insertion of competency framework in appendix

6 Contents 1. Purpose of Protocol 2. Rationale 3. Principles 4. Authority to proceed a. Staff groups b. Consent 5. Training/ Skills a. Training programme b. Continuing training requirements 6. Eligibility Criteria a. Criteria for inclusion b. Criteria for exclusion/ further advice/action c. Treatment, route administration and legal status d. Special circumstances e. Recordkeeping and audit f. Significant Events 7. References 8. Appendices

7 1. Purpose of Protocol To enable suitably trained Health Care Assistants (HCAs) and other Health Care Support workers (HCSWs) working for or on behalf of Liverpool Community Health (LCH) who have undertaken relevant training (section 5), to administer appropriately inactivated Influenza vaccine to adults aged 16years and over. The vaccine would be administered as a single dose, as a duty authorised and assigned by the Registered Nurse or GP (LCH employee) under a Patient Specific Direction (PSD). It will ensure that all staff employed by LCH or on behalf of the Trust, provide optimal service delivery to this population group. The advice and guidance contained within this protocol is based upon the latest research-based evidence (Department of Health, Immunisation Against Infectious Disease. The Green Book (2006) on line version available at: National and local policy documents i.e. The DH Green Book (2006, updated on line version), the LCH Clinical Policy for Vaccine Administration and Protocol for Administration of Inactivated Pneumococcal Vaccine should be read in conjunction with this protocol. Website links are referred to within this document. 2. Rationale To ensure patients/staff receive the highest possible level of care during the administration of vaccines HCSWs are able, with appropriate training and support to undertake tasks that were previously performed by registered staff when authorised to do so via a Patient Specific Direction (PSD). In order to provide LCH resilience there is a requirement for immuniser capacity and the ability to mobilize staff to support the implementation of public health contingency plans, in particular the administration of Influenza and Pneumococcal vaccinations during peaks of seasonal flu activity and for any future Flu pandemics. An essential element to the development of this protocol is to ensure HCSWs have access to specific guidance in vaccine administration. This protocol underpins a recognised set of competencies and meets an agreed standard of risk management. LCH has developed a sustainable training/education programme ensuring consistency but tailored to HCA/HCSWs individual needs based on HPA National Minimum Standards and Core Curriculum for Immunisation Training, LCH Training is also in line with the more recent publication, the National Minimum Standards and Core Curriculum for Immunisation Training of HCSWs (2012) available at: Diseases/Immunisation/1205NationalstandardsimmunisationtrainingHCSW/.

8 3. Principles The vaccination by suitably qualified and trained HCAs /HCSWs will be administered under a Patient Specific Direction (PSD), (section 4c). A PSD is a written instruction by a prescriber, usually the GP or nurse with extended prescribing rights and is written for each individual patient. This may take the form of a list of patients (several named patients) who require vaccination. This instruction may be hand written or entered into each individual patient s electronic notes/ record. HCAs and HCSWs will undertake bespoke training as developed by the LCH Vaccination and Immunisation Training Lead / Immunisation Trainer. Achievement of basic life support training to include the recognition and treatment of anaphylaxis is a pre requisite. HCAs and HCSWs will undertake as a pre requisite Demonstrate the ability to study at level 3 More information is available on the Skills for Health NHS career framework available at: Complete bespoke LCH V & I Foundation raining Achievement of basic life support training to include the recognition and treatment of anaphylaxis See appendix 3 re: Initial Treatment algorithm 4. Authority to Proceed Staff groups Health Care Assistants and Other Health Care Support Workers 4a. Consent Consent must be obtained prior to proceeding with vaccination. Refer to Liverpool Community Health (LCH) Consent Policy at: An adult must consent to their own treatment. The Mental Capacity Act 2005 sets out how treatment decisions should be made for people of 16years of age or older who do not have the capacity to make such decisions. 4b.Patient identification This is required prior to administration of a vaccine. Patient must confirm:

9 4c.Patient specific Directive Name, date of birth, and home address HCA/HSW must confirm that the client is eligible to receive the vaccination as per Green Book inclusion criteria A Valid Patient Specific Direction (PSD) must be obtained. A PSD is a written instruction from an independent prescriber (doctor dentist or independent nurse prescriber) to another healthcare professional, to supply and/or administer a medicine directly to a named patient, or to several named patients. This must be obtained prior to administration of the vaccine 5. Training / Skills 5a. Initial Training Completion of Consent to Treatment training Completion of Basic Life Support training Completion of Infection Control Training The above training will be completed as a pre-requisite to Completion of HCA training course on administration of Influenza and Pneumococcal vaccines to adults Completion of period of supervised practice and assessment against competencies as per National Minimum Standards and Core Curriculum for Immunisation Training of HCSWs (2012) available at: on/1205nationalstandardsimmunisationtraininghcsw/ Training and competence in the correct procedure of administering medication via intra-muscular injection with reference to LCH guidelines competency framework within the appendix Training to include maintenance of patient/client privacy and dignity at all times and the demonstration at assessment of awareness of different possible injection sites if client has any physical disability eg. Amputation Basic Life Support recognition and treatment of anaphylaxis Knowledge of the management of Anaphylaxis in the community. Refer to the green book The National Resuscitation Guidelines on Anaphylaxis, 2008 (annotated with NICE guidance July 2012) can be found at: Access to and knowledge of the DH guidance Immunisation against infectious disease Green book is available at:

10 Topics covered 5b. Continuing training requirement Knowledge, skills and practical application relevant to Vaccination and Immunisation Patient / client communication - demonstrating an awareness of Equality & Diversity and access to publications in other languages available at: agingyourorganisation/workforce/equalityanddiversity/index.htm and at: cationsandstatistics/publications/dh_ Appropriate anatomy, physiology and immunology Correct procedure for the administration of the vaccine via intra-muscular injection Vaccine delivery, storage and stock control requirements, maintaining the cold chain Cautions and side effects related to the administration of inactivated Pneumococcal and Influenza vaccination Correct disposal of waste Documentation and policy including accountability and PSDs Legal aspects of drug administration including consent for further information: Response and treatment of adverse reactions including anaphylaxis and Basic Life Support Cold Chain Procedures/Clinical-Policies/Medicines- Management/Cold_Chain_Policy.pdf Response and treatment of adverse reactions including anaphylaxis and Basic Life Support Access to and Knowledge of current infection control policies Annual update in Basic Life Support and treatment of anaphylaxis. Demonstration of competence in relation to this medication within the Personal Development Plan (PDP) and appraisal process (Performance Development Review). Completion of e-learning/attendance at bespoke annual Vaccination & Immunisation update/ refresher as per LCH requirements Any relevant mandatory training introduced by LCH The immuniser will in conjunction with this protocol refer to all current related infection control policies and Maintenance of the Cold Chain Policy available on the clinical policies website:

11 6. Eligibility Criteria and condition to be treated 6a. Criteria for Inclusion Clinical condition to be treated Criteria for inclusion Active Immunisation Against Influenza Disease to all High-risk patients/clients as per DH Recommendations: : All persons who are or will be aged 65 years and over by 31st of March in the relevant financial year Pregnant women at any stage of pregnancy (offered inactivated flu vaccine as per this protocol only) All patients resident in long stay residential accommodation Any adult patient (16 years and over) who has a confirmed diagnosis of one of the following diseases: Chronic heart (excluding uncomplicated controlled hypertension) / renal / respiratory disease including asthmatics that requires repeated use of inhaled or systemic steroids or with previous history of hospital admissions due to asthma Chronic neurological disease stroke, transient ischaemic attack Diabetes mellitus Chronic liver disease Immunosuppression (due to treatment or disease including asplenia or splenic dysfunction and HIV infection at all stages refer to GP for individual assessment) Main carer for elderly or disabled person A valid PSD for all of the above A more in depth list of clinical risk factors can be found in the influenza section of the updated on line Green Book Influenza: the green book, chapter 19 - Publications - GOV.UK This list is not exhaustive, referral to a clinician/gp for a clinical judgement re: the benefit of vaccination can be made. Pregnant women should be offered inactivated influenza vaccine. Pregnancy or breastfeeding are not contraindications to receiving inactivated Flu vaccination. The vaccine will protect the unborn baby and the mother from a potentially serious infection (see circumstances for further advice/action section 6b below). 6b. Criteria for Exclusion/ circumstances for further advice/action Patients/ clients with any of the following: Criteria for

12 exclusion No valid consent or unable to give informed consent - No capacity to consent Aged under 16 years will be signposted to GP /Special school nurse for children with complex care needs Current acute febrile illness - immunisation should be postponed until recovered A confirmed anaphylactic reaction to a previous dose of vaccine containing the same antigens, including neomycin or gentamycin (discuss with clinician/gp) None of the influenza vaccines should be given to those who have had: a confirmed anaphylactic reaction to a previous dose of the vaccine, or a confirmed anaphylactic reaction to any component of the vaccine, (other than ovalbumin) see circumstances for further advice or action section below) Fit and well (no co-morbidities) adults under the age of 65yrs other than those stated inclusion criteria (unless has a valid PSD and is over 16 years), for example main carer for an elderly relative or disabled person Individuals with an uncontrolled bleeding disorder i.e. haemophilia. HCA & other HCSWs will need to seek advice as the administration technique required may be deep sub-cutaneous and therefore will require assistance from another healthcare professional skilled in this technique Circumstances for further advice/action Consent refused: from patients with capacity counsel with regards to the risks of influenza infections and the protective effect of the vaccine. Document advice given. If no capacity document best interest decisions Severe reaction to any vaccine, or influenza vaccine or any vaccine component, including Neomycin or Gentamycin; refer to GP Individuals who have egg allergy may be at increased risk of reaction to influenza vaccines. In recent years, inactivated influenza vaccines that are egg-free or have a very low ovalbumin content have become available ovalbumin content less than 0.12 μg/ml (equivalent to 0.06 μg for 0.5 ml dose): ; refer all patients who have a confirmed anaphylaxis to the GP/clinician for assessment for egg Pregnancy and breast feeding are not contraindications to receiving Flu vaccination. Pregnant women are in the clinical at risk criteria for Influenza infection, however pregnant women should be offered the opportunity to discuss their pregnancy with their clinician/gp/ registered nurse in relation to influenza infection and vaccination risks and benefits. History of Guillain - Barre syndrome refer to GP (please

13 note this is not a contra indication but will require a discussion with the GP) Acute febrile illness; rearrange vaccination at a later date *Intanza (Sanofi Pasteur) Vaccine brand is technically an intradermal vaccine administered using an intramuscular technique and is dose age specific refer to clinician / GP/ Registered Nurse for advice Maintain all clients dignity at all times. If client is an amputee utilise available alternate limbs. If no alternative limb is available do not proceed, seek advice from the Immunisation Lead /GP/ registered practice nurse as applicable 6c. Treatment, route, administration and legal status Recommended treatment: Route and legal status Inactivated Influenza vaccine to be administered by intramuscular injection into the deltoid muscle (for individuals with an uncontrolled bleeding disorder refer to GP/ registered nurse for subcutaneous vaccination). If administering Pneumococcal vaccination at the same time, use a different site/limb for injection Further information can be obtained from: Prescription Only Medicine (POM) Dosage Frequency of administration & maximum dosage Follow-up and advice Adults 0.5mls * see circumstances for further advice/action section re: Intanza (Sanofi Pasteur) Vaccine brand dosage In accordance with Department of Health Immunisation Schedule and Patient Specific Direction (PSD) Seasonal flu vaccination is usually carried out between October and February of each year and it would be unusual to carry on vaccinating people, including pregnant women, after that date. HCA/HCSWs should seek advice from the Immunisation Lead or GP who can assess the needs of individual patients, taking into account the level of flu-like illness in the community and the fact that the immune response following flu vaccination takes about two weeks to develop fully. Re -immunisation is not normally advised within a 12 month period. The patient/client should be referred to the GP/registered nurse for advice if re immunisation in

14 the same year is required. Follow any DH guidance during influenza pandemic. Re-vaccination in 12 months with appropriate seasonal vaccine Side effects & their management Local effects: Redness, swelling, hardness at injection site, pain, bruising. A small painless nodule (induration) may also form at the injection site. Systemic side effects: Low grade fever recommended treatment with paracetamol Pyrexia, headache, tiredness, muscle & joint pain etc. Counsel patient that these reactions are rare and usually disappear within 1-2 days. If they do not, or more serious symptoms develop, then the patient should contact the GP Extremely rare side effects: Immediate reactions e.g. Urticaria, angio-oedema, bronchospasm and anaphylaxis see protocol for treatment of anaphylaxis for appropriate management This list is not exhaustive refer to current BNF and SPC for complete list. See Adverse Reaction section for all suspected adverse reactions vaccines 6d. Special Considerations Special considerations/ Concurrent As above seek expert advice/ discuss if previous history of Guilllain Barre Syndrome medication Influenza vaccination is not a contraindication in pregnancy. Patients may be referred to GP for advice. If available a thiomersal free vaccine should be used Vaccine shortage may necessitate the need for prioritisation of influenza vaccination within the at risk groups No drug interactions known The immune response to influenza vaccination is reduced in those who are immunosuppressed or

15 Adverse reactions immunodeficient, including HIV patients. Patients should be individually assessed by the consultant team/gp in relation to the risk versus benefit of immunisation Immunosuppressant therapy e.g. oral corticosteroids Chemotherapy or radiotherapy may result in reduced antibody response. The benefits are such that immunisation should be considered. Refer to Clinician/GP or registered nurse immuniser for advice Ensure that Anaphylactic shock pack is available If general adverse reaction occurs: Record in patients notes Inform patient s GP as soon as possible Local reactions should be referred to a practice nurse or GP Inform line manager and complete DATIX incident form If anaphylactic reaction occurs: Give treatment according to LCH policy on anaphylaxis in the community Record in patients notes Inform patient s GP as soon as possible All suspected adverse reactions to vaccines occurring in individuals where vaccines are labelled with a black triangle ( ) and serious adverse reaction to vaccines should be documented and reported to the Medicines Healthcare products Regulatory Agency (MHRA) via yellow card system. 6e. Record Keeping and Audit Items to be recorded in patient s notes. Please refer to LCH Record keeping Policy available at: Name of drug, dose, route and site of administration Date of administration Legible batch number/s and expiry date (from outer vaccine box packaging) Printed name and legible signature of person administrating drug (written or electronic) and designation Contraindications checked

16 Audit (appendix 5) Action taken if patient refuses vaccine Reactions to vaccination and action taken (see completion of yellow card in adverse reactions section) Health Care Assistants and HCSWs will be expected to participate in audit/evaluation in relation to patient outcomes and the development of this extended role. The LCH Vaccination & Immunisation Lead/ Trainer will monitor adherence of LCH staff to this Protocol during attendance at training that will include: Annual review with LCH Clinical Audit Annual Update Q & A Maintenance of database with record of training Annual Review of Protocol 6f. Significant Events Significant Events (i.e. vaccine error, interruption of cold chain, and Near misses) Any significant event which occurs during or as a result of administration of a vaccine must be reported to the LCH Manager/Registered Nurse. All HCAs /HCSWs signing up to this protocol will be expected to: Participate in audit in relation to patient outcomes and the development of this role according to local governance arrangements Comply with the requirements of all relevant LCH policies applicable to their area of operation and local governance arrangements Report and record incidents to the Registered Nurse/Nurse Manager Report and record incident via LCH DATIX reporting system Report and record all potential near misses or adverse incidents in line with Trust Risk Management policy following the protocol for vaccine error or interruption of the cold chain Relevant Clinical policies can be accessed at: HCAs /HCSWs must be familiar with: 1. NMC Guidelines for the Administration of Medication

17 2007/ NMC Guidelines for Records and Record keeping 3. UK Guidance on Best Practice in Vaccine Administration (2001) 4. National Minimum Standards and Core Curriculum for Immunisation Training of Healthcare Support Workers (HPA April, 2012) and LCH documents as follows: a. Policy for Vaccine Administration (vaccine error flowchart) b. Policy for maintaining Cold Chain (cold chain error flowchart) c. Consent to Treatment d. Needle stick Injury Policy e. Personal Protective Equipment Policy f. Hand Hygiene Policy Protocol on the Administration of Inactivated Influenza Vaccine to Adults by Health Care Assistants and Other Non Registered Healthcare Support Workers (HCSWs) Agreement for appropriately trained Health Care Assistants and other none registered Healthcare Support Workers (HCSWs) within Liverpool Community Health This protocol is to be read, agreed and signed by all Health Care Professionals, Health Care Assistants and other Non registered Healthcare Support Workers (HCSWs) and it applies to: Approved base:.. Staff name: Designation: Signature:. Date:..

18 Managers signature: Date:. The Health Care Professionals, Health Care Assistants and other non registered Healthcare Support Workers (HCSWs) should retain a copy of the document after signing and the original be retained in their personal file. This protocol has been devised by: Signature: Date: Signature: Date: This protocol has been accepted by the Clinical Policies Governance Team and Liverpool Community Health Medicines Management Group: Signature Date: Review: It is the responsibility of the lead of the staff groups to whom this protocol applies to ensure the review process takes place. This protocol becomes valid on [INSERT] and becomes due for review on [INSERT]

19 Appendix one Cold Chain Policy for Medicines (esp. vaccines) for staff involved in immunisation October Version 3.Clinical Policies Group Vs. 3

20 Appendix two Vaccination & Immunisation Optional Checklist Consent Process for Influenza Immunisation (copy for GP notes) Individual organisations may wish to use a consent form or may record the outcome of the discussion with the patient on consent directly onto the clinical system. To be completed by the patient and/or nurse Name of Patient M/F.. Address.. Date of Birth NHS no... Name of GP. Do you feel unwell today? Have you had a previous reaction to flu vaccine or any other vaccine?... Are you allergic to any medication?... *Have you had a previous allergic reaction to eggs or egg products?... **Do you have lowered immunity caused by disease or treatment? E.g. no spleen (or a dysfunctional spleen), steroids, HIV, chemotherapy or radiotherapy. YES/NO YES/NO YES/NO YES/NO YES/NO If you have answered YES to any of the above questions please speak to the nurse before you are given your immunisation. Have the advantages/disadvantages of this immunization been discussed with you?.. YES/NO Have you had advice about side effects, temperature control? Has a patient information leaflet been provided? YES/NO YES/NO *** Are you pregnant? YES/NO Please note a written signature is not a statutory requirement. Valid consent is a process and referral or completion of this checklist will assist in the demonstration of this process. Signature of patient for consent to immunisation... * A YES answer to this must prompt further discussion as to the nature of the allergy. It is ONLY a contra-indication if an anaphylactic reaction has been confirmed ** Lowered immunity may result in reduced vaccine response. The benefits of immunisation are such that they usually outweigh any risks *** Pregnancy is not a contraindication. The vaccine will protect the unborn baby and the mother from a potentially serious infection Please check / take advice from GP or Registered nurse

21

22 Immuniser Competencies for Non Registered staff administering Influenza IM, Pneumococcal Polysaccharide Vaccine and Shingles (herpes zoster) Claire Ashley Immunisation Trainer

23 IMMUNISER COMPETENCIES The national Minimum Standards for Immunisation training and the Core Curriculum for Immunisation Training for healthcare professionals involved in Immunisation describe the standards and list the essential topics which should be incorporated into all immunisation training for registered healthcare professionals. Both these Minimum Standards and the Core Curriculum have been used as the basis for this guidance for HCSW Immunisation training. It is recommended that only HCSWs who have achieved education and training to Level 3 of the Qualifications and Credit Framework ( QCF ) or equivalent in England and Wales with at least 2 years experience as a HCSW should be considered for training in vaccine administration. HCSW s working at this level are likely to be Level Three or above of the NHS Career Framework or the NHS Wales Skills and Career Development Framework for Clinical Healthcare Support Workers. This document adheres to these published principles and aims to build upon the Foundation course outcomes to ensure that practitioners continue to work safely and effectively by applying learning in all of the 14 core curriculum areas of knowledge. Objectives are attained through the Practitioners understanding of immunisation policy and their ability to transfer theory to practice by applying: Multidisciplinary approach Proactive practice to increase sphere of influence Partnership working Evidence based practice Research findings and sharing them with others Active reflection and development Health Care Competencies These are linked to the Skills for Health National Occupational Standards. Workforce competence CHS3 specifically relates to the Administration of Medicines to Individuals. These standards are continually evolving, please refer to the Skills for Health website at for further guidance. Learning outcomes and objectives relate to the 14 core curriculum topics divided into 14 content sections and have been mapped to the six Knowledge and Skills framework (KSF ) core dimensions from Levels 1 through to 3 1. Communication 2. Personal and People Development 3. Health safety and security 4. Service Improvement 5. Quality 6. Equality and Diversity Post Immunisation foundation course, as Practitioners acquire skills, knowledge, understanding and confidence in their field they are able to demonstrate how they meet increasingly challenging levels of competence.

24 Health and well-being (HW) Map to Health and well-being KSF dimensions HWB1, B2, B3, B5, B6, B7 and all 6 core dimensions Section Core areas of knowledge KSF Core dimensions Specific dimensions - applying knowledge and understanding at appropriate level 1 The aims of Immunisation: national policy and schedules 2 The immune system and how vaccines work 1, 2, 3, 4, 5 & 6 HWB1, HWB3, HWB7 1, 4 & 5 HWB1, HWB3 3 Vaccine preventable diseases 1, 3, 4, 5 & 6 HWB1, HWB3, HWB7 4 The different types of vaccines used and their composition 5 Current issues and controversies regarding vaccination and immunisation 6 Communicating with the public (patients/clients, parents and carers) 1, 3, 4 & 5 HWB1, HWB3, HWB7 1, 4, 5 & 6 HWB1, HWB3, HWB5 1, 4, 5 & 6 HWB1 & HWB3 7 Legal aspects of vaccination 1, 4, 5 & 6 HWB2, HWB3, HWB5 & HWB6 8 Storage and handling of vaccines 9 Correct Administration of Vaccines 10 Anaphylaxis and other adverse events 11 Documentation record keeping and reporting 12 Strategies for improving immunisation rates 1, 3, 4, & 5 HWB1, HWB3, HWB7 1, 3, 4, 5, 6 & 7 HWB3, HWB5 HWB6 & HWB7 1, 3, 4, & 5 HWB2, HWB3 & HWB7 1, 4, 5 & 6 HWB1, HWB3 & HWB5 1, 4, 5 & 6 HWB1 & HWB3

25 LCH Claire Ashley Vaccination and Immunisation Trainer v1 WHAT IS COMPETENCE? Competence is acquiring and using evidence based scientific and humanistic knowledge and skill in the application of therapeutic interventions in the current practice of nursing (Roach, 1984) The following document contains a self- assessment section and a section for completion by a mentor and is to be used as a tool to measure and agree competency. Staff will need to identify a mentor who is a registered practitioner and experienced in delivering immunisation programmes. Potential Immunisers should be assessed against all the listed competencies, except where they are only required to use specific techniques eg: intra- dermal vaccination for BCG injection ( TB team ) or intra- nasal Flu vaccinations. In these instances, the documentation should clearly state for which vaccine the assessment has been carried out. If staff work in a signposting role, as opposed to an active immunisation role, they and their assessors need to identify which competencies are applicable to them. Staff evolving from an advisory/support role to an active Immunisation administration role will need to be fully assessed against all competencies and may require further training to accomplish this. After completion of training and a period of supervised practice the practitioner should complete the self- assessment column to state that they feel competent to immunise independently. The mentor should review this self-assessment, having observed them perform immunisations and indicate if each competence is met. If the mentor has cause to write in the attainment pending column, a clear action plan must be put in place that will help the practitioner to attain the required level of competence and a review date should be agreed. When the mentor and the practitioner agree that the practitioner is competent in all areas, the section at the bottom of the register should be signed off. November 2015

26 LCH Claire Ashley Vaccination and Immunisation Trainer v1 2a 2b 2c 2d 2e 2f 2g 2h Staff with a clinical professional registration Knowledge base Must attend a relevant Adult or Child Services Vaccination & Immunisation Foundation course via Liverpool Community Health or accredited external agency. Can evidence successful completion of all course MCQ tests during the relevant Foundation training. Can access the Green Book online, aware it is updated electronically only. Seeks advice from appropriate personnel should queries arise re: vaccine eligibility, spacing or error. Demonstrates awareness of the national and local immunisation programmes and vaccine preventable diseases. Understands vaccine types eg: can explain live and inactivated vaccines and demonstrates knowledge of different delivery routes eg: subcutaneous, intra-nasal. Understands the need for booster doses, vaccine spacing and the rationale behind the flu vaccine being administered annually. Knows the vaccination targets, locally and nationally and understands the importance of uptake data. N/A to current area of practice Self assessment record Attained Mentor review record Attained (A) Attainment pending (AP) Action plan for attainment ( if pending ) Review date November 2015

27 LCH Claire Ashley Vaccination and Immunisation Trainer v1 Essential core skills for Immunisation 3a Demonstrates knowledge and understanding of the need for cold chain maintenance. Can access LCH Cold chain policy, if LCH employed. Can access local cold chain policy if GP employed. Understands how to action and correctly report any cold chain failure that occurs on or off LCH premises. If vaccine transportation is an integral part of role can demonstrate ability to safely transport vaccines ensuring cold chain maintenance throughout the immunisation session. 3b Is in date with mandatory CPR and anaphylaxis training training is on an annual basis for LCH staff. Knows what course of action should be taken if the Immuniser is out of compliance with mandatory CPR. Aware of local protocols for the transportation of adrenaline. Can advise where emergency kits are held at different clinical locations, if applicable. 3c Demonstrates good hand hygiene and Infection prevention techniques. 3d Knows the local reporting responses to clinical/procedural incidents eg: needlestick injury. Knows how to access and complete Datix or equivalent. Knows how to access relevant policies/protocols on the LCH Intranet if access is available or else can identify locally held policies/protocols. 3e Adheres to local guidance and best practice in relation to sharps/equipment disposal. Works to aide-memoir from LCH V & I policy if November 2015

28 LCH Claire Ashley Vaccination and Immunisation Trainer v1 LCH employed or from local SOP ( Standard Operating Procedure ) if GP employed. Understands limitations of own role and knows where to seek advice with any queries. PROCESS / PROCEDURE 4a Determines patients immunisation history by carrying out appropriate identity and record checks, using GP data systems, checks EMIS if all previous checks reveal no immunisation history. Is able to correctly state which vaccines patient is eligible for, according to the UK programme. 4b Demonstrates the ability to give comprehensive vaccine advice to ensure best practice for informed consent. Uses leaflets/aids to compound information given verbally. Can contact LCH or external Interpreter services if language barrier exists to ensure informed consent takes place. 4c Demonstrates a clear understanding of the risks and benefits of vaccination. Is able to address queries and clarify any controversial issues eg: the use of porcine gelatin in certain vaccines. Able to address misconceptions and certain myths eg: flu vaccine causes flu, 2015 flu vaccine didn t work. 4d Understands consent requirements, demonstrates knowledge of the Mental Capacity Act and Gillick Competence. Always ensures consent is appropriately obtained prior to vaccination and documents accordingly. Understands best interest concept and can name appropriate staff members to help with November 2015

29 LCH Claire Ashley Vaccination and Immunisation Trainer v1 this. Always documents consent prior to procedure. 4e Demonstrates some awareness of childhood consent issues ( Childhood flu programme only )eg: who has parental responsibility. Awareness of safeguarding issues eg: therapeutic holding. Knows to refer to registered practitioner if any doubt/ confusion arises eg: looked after children. 4f Understands contra-indications/cautions and successfully follows check list /algorithm to check it is safe to proceed with vaccination. Contacts relevant registered/medical practitioner if any doubt exists. 4g Understands a Patient Specific Direction ( PSD ) is the authority to proceed with vaccination, checks it is current, signed by a prescriber and completed correctly before immunisation session begins. 4h Can name all advanced prescribers in the relevant clinical area. 4i Understands that PGD for intra-nasal child vaccine covers the supply of the vaccine only. Robust protocols should be in place locally to cover the administration of this vaccine. 4j Checks vaccines have been stored correctly, uses Summary of Product Characteristics ( SPC ), checks vaccine box for damage and checks expiry date. 4k Uses correct position, site and route of administration for individual vaccines. 4l Demonstrates correct intra- muscular injection technique for Flu/Pneumococcal vaccines. November 2015

30 LCH Claire Ashley Vaccination and Immunisation Trainer v1 4m 4n 4o 4p 4q Demonstrates correct intra-muscular technique for Shingles vaccine. Demonstrates correct technique for childhood vaccines. ( Minimum 10 ) Completes necessary documentation. Records; date, vaccine type, manufacturer, dose given, batch no:, expiry date, injection site ( if injectable ), eg, administered via PGD or PSD, name and signature of Immuniser. Uses EMIS correctly. Understands how and when to report reactions to vaccines to the MHRA via the Yellow card system. Also understands the local procedures for reporting adverse events. Understands the Anticipated Effects Following Immunisation ( AEFI s ) and can offer advice on symptom control. Provides patient/parent with a copy of post immunisation advice sheets. Knows how to order advice leaflets from Orderline. November 2015

31 LCH Claire Ashley Vaccination and Immunisation Trainer v1 REFERENCES Liverpool Community Health Vaccination & Immunisation Policy Liverpool Community Health Meds Management Cold Chain Policy Royal College of Nursing ( 2015 ) Supporting the delivery of immunisation education.london: RCN Health Protection Agency (2005 )National Minimum standards and core curriculum of immunisation training of health care support workers. London: Public Health England (previous HPA) Available at -minimum-standards NMC Code of Conduct Against-Infectious-Disease Green Book Roach,M.S. (1984 )Caring: The Human Mode of Being, Implications for Nursing.Ottowa: The Canadian Hospital Assosciation Press NMC 2010 Standards for Medicines Management Public Health England ( 2015 ) National Minimum Standards and core curriculum of immunisation training of health care support workers. London. Public Health England ( previous HPA ).Available at : - core-curriculum November 2015

Protocol for the Administration of Inactivated Influenza Vaccine to. Adults by Registered Nurses via Patient Specific Direction

Protocol for the Administration of Inactivated Influenza Vaccine to. Adults by Registered Nurses via Patient Specific Direction This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational change this

More information

Trust-wide. Minor Change. Major Change

Trust-wide. Minor Change. Major Change Policy Number 110 This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational

More information

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the Document Details Title Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No 1506-41174 Local Ref (optional) Main points the Active immunisation against infection caused by Hepatitis

More information

Document Details. Patient Group Direction

Document Details. Patient Group Direction Document Details Title Patient Group Direction (PGD) Hepatitis B Vaccine (Engerix ) Trust Ref No 1505-41182 Local Ref (optional) Main points the Immunisation against Hepatitis B document covers Who is

More information

CLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR PNEUMOCOCCAL CONJUGATE VACCINE (Prevenar 13 )

CLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR PNEUMOCOCCAL CONJUGATE VACCINE (Prevenar 13 ) Patient Group Direction for Pneumococcal Conjugate Vaccine (Prevenar 13 ) Version: PNEUMOCOCCAL CONJUGATE 2014.1 Start 1 st February 2014 Expiry 31 st January 2017 THIS PATIENT GROUP DIRECTION HAS BEEN

More information

THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:

THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: Patient Group Direction for Pneumococcal polysaccharide vaccine VERSION: PNEUMOCOCCAL POLY-2013.1 (Pneumovax II ) Start 1 st May 2013 Expiry 30 th April 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED

More information

SAMPLE. PGD reviewed by: Dr Tim Patterson, Chris Faldon, John Maloney, Adrian Mackenzie

SAMPLE. PGD reviewed by: Dr Tim Patterson, Chris Faldon, John Maloney, Adrian Mackenzie Patient Group Direction for the Supply or Administration of combined Diphtheria, Tetanus, acellular Pertussis, inactivated Polio vaccine and Haemophilus type b conjugate Vaccine (Infanrix-IPV-HIB) to children

More information

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Title Document Details Patient Group Direction (PGD) Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Trust Ref No 1445-36348 Local Ref (optional) Main points the document The treatment of

More information

SAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein

SAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein Patient Group Direction for the supply or administration of haemophilus influenzae type B and meningococcal conjugate vaccine to children requiring immunisation as part of the national childhood vaccination

More information

Patient Group Direction For The Administration Of H1N1 (Swine Flu) vaccine

Patient Group Direction For The Administration Of H1N1 (Swine Flu) vaccine n Patient Group Direction For The Administration Of H1N1 (Swine Flu) vaccine October 2009 PGD version template-2009.1 Page 1 of 8 Rationale Patient Group Direction For The Administration Of H1N1 (Swine

More information

This document expires on Patient Group Direction No. VI 11

This document expires on Patient Group Direction No. VI 11 Patient Group Direction (PGD) for The Administration of Combined Inactivated Hepatitis A & Hepatitis B Vaccine (Twinrix adult, Twinrix paediatric) to Adults and Children over one year by Registered Nurses

More information

Enhanced Service Specification. Childhood seasonal influenza vaccination programme 2017/18

Enhanced Service Specification. Childhood seasonal influenza vaccination programme 2017/18 Enhanced Service Specification Childhood seasonal influenza vaccination programme 2017/18 2 Enhanced Service Specification Childhood seasonal influenza vaccination programme Version number: 1 First published:

More information

GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation of individuals

More information

Enhanced Service Specification. Childhood seasonal influenza vaccination programme 2018/19

Enhanced Service Specification. Childhood seasonal influenza vaccination programme 2018/19 Enhanced Service Specification Childhood seasonal influenza vaccination programme 2018/19 Contents Childhood seasonal influenza vaccination programme... 1 Contents... 4 1 Introduction... 5 2 Background...

More information

Patient Group Direction For the supply and administration of

Patient Group Direction For the supply and administration of Patient Group Direction For the supply and administration of Adsorbed low dose DIPHTHERIA/TETANUS/acellular PERTUSSIS/ inactivated POLIO REPEVAX Vaccine (dtap/ipv) Or Adsorbed DIPHTHERIA/TETANUS/acellular

More information

Patient Group Direction For the supply and administration of

Patient Group Direction For the supply and administration of Patient Group Direction For the supply and administration of COMBINED HEPATITIS A AND HEPATITIS B VACCINE TWINRIX PAEDIATRIC For Children aged 1 year to under 16 years TWINRIX ADULT For Adults and Adolescents

More information

CONJUGATE MENINGOCOCCAL (ACWY) VACCINE

CONJUGATE MENINGOCOCCAL (ACWY) VACCINE Cumbria & Lancashire Vaccine PGD Group ADVISORY INFORMATION FOR USE WITH PATIENT SPECIFIC DIRECTION OR INDIVIDUAL PRESCRIPTION SIGNED BY GP OR NON-MEDICAL PRESCRIBER. CONJUGATE MENINGOCOCCAL (ACWY) VACCINE

More information

Community Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services

Community Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF HEPATITIS A VACCINE (HAVRIX MONODOSE VACCINE) BY REGISTERED NURSES WORKING IN THE COMMUNITY SUBSTANCE MISUSE TEAMS Version Number : 2 Patient Group

More information

This document expires on Patient Group Direction No. VI 5

This document expires on Patient Group Direction No. VI 5 Patient Group Direction (PGD) for The Administration of Combined Adsorbed Diphtheria, Tetanus, Pertussis, (Acellular Component) and Inactivated Poliomyelitis Vaccine (Infanrix-IPV ) to children aged between

More information

Patient Group Direction Hepatitis A vaccine Version: Hepatitis A 2015 Start Date: 1 st July 2015 Expiry Date:30 th June 2018

Patient Group Direction Hepatitis A vaccine Version: Hepatitis A 2015 Start Date: 1 st July 2015 Expiry Date:30 th June 2018 Patient Group Direction Hepatitis A vaccine Version: Hepatitis A 2015 Start 1 st July 2015 Expiry 30 th June 2018 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: BLACKPOOL

More information

Administration of Hepatitis A and B Vaccine

Administration of Hepatitis A and B Vaccine PRACTICE: Ref No: PGD/ONEL/2011/006 Valid from December 2011 Valid to December 2013 Supersedes PGD: Any previous PGD used to administer Twinrix Adult and Paediatric vaccine Professional groups covered

More information

GG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

GG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT GG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Active immunisation

More information

This document expires on Patient Group Direction No. VI 7

This document expires on Patient Group Direction No. VI 7 Patient Group Direction (PGD) for The Administration of Combined low-dose Diphtheria, Tetanus, and Inactivated Polio Vaccine (Revaxis ) to individuals aged over 10 years, by Registered Nurses employed

More information

Patient Group Direction For the supply and administration of

Patient Group Direction For the supply and administration of Patient Group Direction For the supply and administration of HAEMOPHILUS INFLUENZAE TYPE B AND MENINGOCOCCAL C CONJUGATE VACCINE (HIB-MenC) MENITORIX Vaccine By Registered Nurse/Midwife/Health Visitor

More information

Patient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st May 2014 Expiry Date: 30 th April 2017

Patient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st May 2014 Expiry Date: 30 th April 2017 Patient Group Direction for Varicella vaccine Version: Varicella 2014.1 Start Date: 1 st May 2014 Expiry Date: 30 th April 2017 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:

More information

Document Details. Patient Group Direction

Document Details. Patient Group Direction Document Details Title Patient Group Direction (PGD) Salbutamol Aerosol Inhaler and salbutamol Nebulised Solution Trust Ref No 1569-34313 Local Ref (optional) Main points the document Treatment of acute

More information

This document expires on Patient Group Direction Number VI 19

This document expires on Patient Group Direction Number VI 19 Patient Group Direction (PGD) for The Administration of Pneumococcal Polysaccharide Vaccine (PPV, Pneumovax II ) to adults over 65 years and at risk groups aged 2 years and over, by Registered Nurses employed

More information

PATIENT GROUP DIRECTION. Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif )

PATIENT GROUP DIRECTION. Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif ) PATIENT GROUP DIRECTION Administration of: Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif ) By: Practice Nurses In: General Practice It is the responsibility of the professional working under

More information

Prescription only medicines (POMs)

Prescription only medicines (POMs) Prescription only medicines (POMs) 2017 Learning objectives Explain the legal framework with which registered health care professionals can administer prescription only medicines Define the role and limitations

More information

Enhanced service specification Childhood seasonal influenza vaccination programme NHS England gateway reference: 01641

Enhanced service specification Childhood seasonal influenza vaccination programme NHS England gateway reference: 01641 Enhanced service specification Childhood seasonal influenza vaccination programme NHS England gateway reference: 01641 Introduction 1. All GMS practices are expected to provide essential and those additional

More information

Influenza Vaccinations: Procedure for the Ordering and Administration at Hospitals and Hostels within SHFT

Influenza Vaccinations: Procedure for the Ordering and Administration at Hospitals and Hostels within SHFT SH CP 117 Influenza Vaccinations: Procedure for the Ordering and Administration at Hospitals and Hostels within SHFT Summary: Ordering and Administration of Influenza Vaccinations at Hospitals and Hostels

More information

Patient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B Start Date: 1 st January 2014 Expiry Date: 31 st December 2015

Patient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B Start Date: 1 st January 2014 Expiry Date: 31 st December 2015 Patient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B 2014.1 Start 1 st January 2014 Expiry 31 st December 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:

More information

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF PROCEDURE: Medicines Procedure: Patient Group Directions for the Administration of Hepatitis B Vaccine for SABP Drug and Alcohol Teams. PURPOSE OF PROCEDURE:

More information

GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against disease

More information

Clinical Condition Indication:

Clinical Condition Indication: GG&C PGD ref no: 2016/1366 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against disease

More information

Patient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st April 2016 Expiry Date: 31 st March 2019

Patient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st April 2016 Expiry Date: 31 st March 2019 Patient Group Direction for Varicella vaccine Version: Varicella 2016.1 Start Date: 1 st April 2016 Expiry Date: 31 st March 2019 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:

More information

Patient Group Directions (PGDs)

Patient Group Directions (PGDs) Patient Group Directions (PGDs) Document level: Trustwide (TW) Code: MP2 Issue number: 4 Lead executive Authors details Type of document Target audience Document purpose Medical Director Senior Clinical

More information

Patient Group Direction

Patient Group Direction This Patient Group Direction (PGD) must only be used by registered health professionals who have been named and authorised by their organisation to practice under it. The most recent and in date final

More information

by registered nurses employed by NHS Hertfordshire or Hertfordshire GP Practices and signatories to the PGD

by registered nurses employed by NHS Hertfordshire or Hertfordshire GP Practices and signatories to the PGD Notice to all staff: NHS Hertfordshire Patient Group Directions (PGDs) may only be used by members of the healthcare professions named on the title page and only if each professional has individually been

More information

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

South Staffordshire and Shropshire Healthcare NHS Foundation Trust South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Immunisation Policy YELLOW - Clinical New or Replacing:

More information

Management of AIDS/HIV Infected Healthcare Workers Policy

Management of AIDS/HIV Infected Healthcare Workers Policy Management of AIDS/HIV Infected Healthcare Workers Policy DOCUMENT CONTROL: Version: 4 Ratified by: Corporate Policy Panel Date ratified: 20 July 2017 Name of originator/author: HR Manager Name of responsible

More information

Developed By Name Signature Date

Developed By Name Signature Date Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:

More information

PATIENT GROUP DIRECTION PROCEDURE

PATIENT GROUP DIRECTION PROCEDURE PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen

More information

Patient Group Direction

Patient Group Direction Patient Group Direction For the supply and administration of PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT) PNEUMOVAX II Vaccine By Registered Nurse/Midwife/Health Visitor To Adults and children over

More information

Assistant Practitioner and Health Care Assistants Administration of Insulin, via Pen device, by Delegation Training and competency Toolkit

Assistant Practitioner and Health Care Assistants Administration of Insulin, via Pen device, by Delegation Training and competency Toolkit Assistant Practitioner and Health Care Assistants Administration of Insulin, via Pen device, by Delegation Training and competency Toolkit Document Summary The purpose of this policy is to guide and promote

More information

Clinical Condition Indication:

Clinical Condition Indication: Patient Group Direction ( for Health Care GG&C PGD ref no: 2018/1611 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition

More information

Case scenarios: Patient Group Directions

Case scenarios: Patient Group Directions Putting NICE guidance into practice Case scenarios: Patient Group Directions Implementing the NICE guidance on Patient Group Directions (MPG2) Published: March 2014 [updated March 2017] These case scenarios

More information

Change history Version number Change details Date Updated for National ACWY programme to be implemented August June 2015.

Change history Version number Change details Date Updated for National ACWY programme to be implemented August June 2015. Patient Group Direction for Conjugate Meningococcal ACWY vaccine Version: MEN ACWY CONJUGATE 2015.1 Start 1 st August 2015 Expiry 31 st July 2018 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING

More information

Flu vaccination service All you need to know to make a success of the new service. Alastair Buxton Leyla Hannbeck Fin Mc Caul

Flu vaccination service All you need to know to make a success of the new service. Alastair Buxton Leyla Hannbeck Fin Mc Caul Flu vaccination service All you need to know to make a success of the new service Alastair Buxton Leyla Hannbeck Fin Mc Caul Objectives: Understand exactly how the service will work and how to make your

More information

Clinical Condition Indication:

Clinical Condition Indication: GG&C PGD ref no: 2012/943 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation of individuals

More information

Patient Group Directions Policy

Patient Group Directions Policy Patient Group Directions Policy Category: Summary: Equality Analysis undertaken: Valid From: Date of Next Review: Approval Date/ Via: Distribution: Related Documents: Author(s): Further Information: This

More information

GG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

GG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT GG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against rotavirus.

More information

GG&C PGD ref no: 2018/1589 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

GG&C PGD ref no: 2018/1589 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT GG&C PGD ref no: 2018/1589 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Individuals requiring active immunisation

More information

HEPATITIS A + TYPHOID VACCINE

HEPATITIS A + TYPHOID VACCINE GG&C PGD ref no: 2017/1522 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Indicated for active immunisation

More information

Influenza Preparedness Peer Vaccination Campaign in a Community Hospital

Influenza Preparedness Peer Vaccination Campaign in a Community Hospital Influenza Preparedness Peer Vaccination Campaign in a Community Hospital By; Patricia Mc Enery-Noonan A/Director of Nursing Listowel Community Hospital 19 th September 2018 Peer To Peer Vaccination Seasonal

More information

patient group direction

patient group direction REVAXIS v01 1/12 REVAXIS (DIPHTHERIA, TETANUS AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED, REDUCED ANTIGEN(S) CONTENT)) PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic

More information

PGD No Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 - Gardasil - September 2012

PGD No Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 - Gardasil - September 2012 Notice to all staff: NHS Hertfordshire Patient Group Directions (PGDs) may only be used by members of the healthcare professions named on the title page and only if each professional has individually been

More information

flu vaccination DRAFT The WINTER 2018/19 Who should have it and why Includes information for children and pregnant women mmunisation

flu vaccination DRAFT The WINTER 2018/19 Who should have it and why Includes information for children and pregnant women mmunisation flu vaccination Who should have it and why The WINTER 2018/19 Includes information for children and pregnant women The flu vaccination 1 Winter 2018/19 Flu mmunisation Helping to protect everyone, every

More information

Equality of Opportunity Committee

Equality of Opportunity Committee Equality of Opportunity Committee EOC(3)-12-09 (p8) Inquiry into Discrimination against People Living with HIV by Healthcare Professionals and Providers Written evidence from Abertawe Bro Morgannwg University

More information

Patient Group Direction For the supply and administration of

Patient Group Direction For the supply and administration of Patient Group Direction For the supply and administration of Adsorbed low dose DIPHTHERIA/TETANUS/acellular PERTUSSIS/ inactivated POLIO REPEVAX Vaccine (dtap/ipv) By Registered Nurse/Midwife/Health Visitor

More information

NHS public health functions agreement Service specification No.32 Human papillomavirus immunisation programme for men who have sex with men

NHS public health functions agreement Service specification No.32 Human papillomavirus immunisation programme for men who have sex with men NHS public health functions agreement 2018-19 Service specification No.32 Human papillomavirus immunisation programme for men who have sex with men (HPV-MSM) 1 NHS public health functions agreement 2018-19

More information

standards for vaccinators and guidelines for organisations offering immunisation services

standards for vaccinators and guidelines for organisations offering immunisation services standards for vaccinators and guidelines for organisations offering immunisation services A3.1 Purpose The Immunisation standards for vaccinators (see section A3.3) are quality levels all vaccinators should

More information

BASIC IMMUNISATION FOR NEW IMMUNISERS. Alison Johnson Immunisation Facilitator.

BASIC IMMUNISATION FOR NEW IMMUNISERS. Alison Johnson Immunisation Facilitator. BASIC IMMUNISATION FOR NEW IMMUNISERS Alison Johnson Immunisation Facilitator. Contents. Why vaccinate? Basic Immunology UK immunisation programme/selective Policies and guidelines. Cold chain Consent

More information

Developed By Name Signature Date

Developed By Name Signature Date Patient Group Direction 2156 version 2.0 Administration of Ipratropium 250mcg/ml Nebuliser Solution in Acute Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Date of

More information

Berkshire School Aged Immunisation Team Seasonal Influenza 2018/19

Berkshire School Aged Immunisation Team Seasonal Influenza 2018/19 Dear Parent/ Carer Re: Seasonal Influenza Vaccinations (flu) for children from Reception to year 5 This autumn the school immunisation team will be returning to your child s school to offer the seasonal

More information

Patient Group Direction No. VI 17. Kathy Wakefield/Lisa Murray. General Practices & TRFT. Relevant Clinical Lead

Patient Group Direction No. VI 17. Kathy Wakefield/Lisa Murray. General Practices & TRFT. Relevant Clinical Lead T i:1 Patient Group Direction (PGD) for The Administration of Meningococcal Group C Conjugate Vaccine (Meningitec /NeisVac-C /Menjugate Kit ) by Registered Nurses employed or commissioned by NHS Rotherham

More information

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department

More information

Model the social work role, set expectations for others and contribute to the public face of the organisation.

Model the social work role, set expectations for others and contribute to the public face of the organisation. AMHP Competency PCF capability mapping: Experienced level social worker. 1. Professionalism: Identify and behave as a professional social worker, committed to professional development: Social workers are

More information

Health and Social Care Workers and Pandemic Influenza

Health and Social Care Workers and Pandemic Influenza Health and Social Care Workers and Pandemic Influenza Information for staff who are pregnant or in DH INFORMATION READER BOX Policy HR / Workforce Management Planning / Clinical Document Purpose Gateway

More information

Influenza Campaign (Wales) Code of Practice (The Flu Code)

Influenza Campaign (Wales) Code of Practice (The Flu Code) Influenza Campaign (Wales) Code of Practice (The Flu Code) May 2016 Public Health Wales Influenza Campaign (Wales) Code of Practice Purpose and Summary of Document: This code of practice sets out the minimum

More information

Patient Group Direction For the supply and administration of

Patient Group Direction For the supply and administration of Patient Group Direction For the supply and administration of Vi Capsular Polysaccharide Typhoid Vaccine(Ty2) Brands TYPHERIX Vaccine TYPHIM Vi Vaccine To adults and/or children over 2 years of age Or Oral

More information

Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure

Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Quality Assurance Sub Committee Date ratified: 4 September

More information

COMPETENCES REQUIRED FOR APPLICANTS TO ATTAIN HPC REGISTRATION AS CLINICAL SCIENTISTS

COMPETENCES REQUIRED FOR APPLICANTS TO ATTAIN HPC REGISTRATION AS CLINICAL SCIENTISTS This document comprises a discipline-specific version of the general competence document and provides additional guidance as to how to complete the general document, Appendix 1 of the Guidelines, that

More information

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group BEFORE USING THIS POLICY ALWAYS ENSURE YOU ARE USING THE MOST UP TO DATE VERSION Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical

More information

TRUST WIDE DOCUMENT DOCUMENT NUMBER: ELHT Version 1

TRUST WIDE DOCUMENT DOCUMENT NUMBER: ELHT Version 1 i TRUST WIDE DOCUMENT DOCUMENT TITLE: SEASONAL INFLUENZA PLAN DOCUMENT NUMBER: ELHT Version 1 DOCUMENT PURPOSE: Seasonal Influenza (Flu) Plan sets out a coordinated and evidence-based approach to planning

More information

Trust Policy 218 Ionising Radiation Safety Policy

Trust Policy 218 Ionising Radiation Safety Policy Trust Policy 218 Ionising Radiation Safety Policy Purpose Date Version August 2016 7 To ensure that Plymouth Hospitals NHS Trust complies with all relevant legislation with regard to the use of ionising

More information

Patient Group Direction for HEPATITIS A AND TYPHOID VACCINE. Version No.: 4/2014. Hitesh Patel Pharmaceutical Adviser, NHS Telford & Wrekin CCG

Patient Group Direction for HEPATITIS A AND TYPHOID VACCINE. Version No.: 4/2014. Hitesh Patel Pharmaceutical Adviser, NHS Telford & Wrekin CCG Document Title: Patient Group Direction for HEPATITIS A AND TYPHOID VACCINE PCT Doc Ref.: Local Doc Ref.: PGD Version No.: 4/2014 Author/Owner: File Reference: Document Overseeing Group: Hitesh Patel Pharmaceutical

More information

Patient Group Direction for SALBUTAMOL INHALER (Version 02) Valid From 1 October September 2019

Patient Group Direction for SALBUTAMOL INHALER (Version 02) Valid From 1 October September 2019 Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history

More information

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices Name of Dental Practice : Objectives To ensure implementation of the regulations and guidance on safe and secure handling of midazolam and other controlled drugs (CDs) Scope To cover all aspects of obtaining

More information

Local Enhanced Service Specification. MenACWY vaccination programme for 15 and 16 year olds (school year 11) in Cornwall and the Isles of Scilly

Local Enhanced Service Specification. MenACWY vaccination programme for 15 and 16 year olds (school year 11) in Cornwall and the Isles of Scilly Local Enhanced Service Specification MenACWY vaccination programme for 15 and 16 year olds (school year 11) in Cornwall and the Isles of Scilly 1 st January 2016 to 31 st August 2016 1 Local Enhanced Service

More information

PATIENT GROUP DIRECTION (PGD) Supply of potassium iodide 65mg tablets to adults and children exposed to, or at risk of exposure to radioactive iodine

PATIENT GROUP DIRECTION (PGD) Supply of potassium iodide 65mg tablets to adults and children exposed to, or at risk of exposure to radioactive iodine PHE publications gateway number: PATIENT GROUP DIRECTION (PGD) Supply of potassium iodide 65mg tablets to adults and children exposed to, or at risk of exposure to radioactive iodine For the supply of

More information

NHS Sheffield Community Pharmacy Seasonal Flu Vaccination Programme for hard to reach at risk groups (and catch up campaign for over 65s)

NHS Sheffield Community Pharmacy Seasonal Flu Vaccination Programme for hard to reach at risk groups (and catch up campaign for over 65s) NHS Sheffield Community Pharmacy Seasonal Flu Vaccination Programme for hard to reach at risk groups 2012-13 (and catch up campaign for over 65s) Service Evaluation! Supported by Sheffield!Local!Pharmaceutical!Committee!

More information

UNSCHEDULED VACCINATION OF CHILDREN AND YOUNG PEOPLE WHO HAVE OUTSTANDING ROUTINE IMMUNISATIONS. Service Specification

UNSCHEDULED VACCINATION OF CHILDREN AND YOUNG PEOPLE WHO HAVE OUTSTANDING ROUTINE IMMUNISATIONS. Service Specification UNSCHEDULED VACCINATION OF CHILDREN AND YOUNG PEOPLE WHO HAVE OUTSTANDING ROUTINE IMMUNISATIONS Service Specification National Enhanced Service Specification For The Unscheduled Vaccination Of Children

More information

Seasonal Influenza Peer Vaccination Programme Immunisation Process

Seasonal Influenza Peer Vaccination Programme Immunisation Process Seasonal Influenza Peer Vaccination Programme 2018 Immunisation Process Overview of Continuous Professional Education on Immunisations for Registered Nurses and Midwives 1. Introduction to Seasonal Influenza

More information

Consultation Group: See relevant page in the PGD. Review Date: October 2017

Consultation Group: See relevant page in the PGD. Review Date: October 2017 Patient Group Direction For Supply Of Paracetamol Oral Suspension 120mg/5mL For Prevention Of Post Immunisation Fever Following Administration Of Meningococcal Group B Vaccine (Bexsero ) By Community Pharmacists

More information

Specialised Services Commissioning Policy. CP29: Bariatric Surgery

Specialised Services Commissioning Policy. CP29: Bariatric Surgery Specialised Services Commissioning Policy CP29: Bariatric Surgery Document Author: Specialist Planner, Cardiothoracic Executive Lead: Director of Planning Approved by: Management Group Issue Date: 12 June

More information

Administration of shingles (herpes zoster) vaccine (live) Zostavax. Version 7.0 updated for programme from September 2017 to August 2018

Administration of shingles (herpes zoster) vaccine (live) Zostavax. Version 7.0 updated for programme from September 2017 to August 2018 Patient Group Direction template Administration of shingles (herpes zoster) vaccine (live) Zostavax Version 7.0 updated for programme from September 2017 to August 2018 This specimen Patient Group Direction

More information

NO SMOKING POLICY. Organisational

NO SMOKING POLICY. Organisational NO SMOKING POLICY Policy Title State previous title where relevant. State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For clinical policies only - state index

More information

Version Number: 02. Patient Group Direction drawn up by: Jayne Bruce - Deputy Director of Nursing Standards and Safety Sussex

Version Number: 02. Patient Group Direction drawn up by: Jayne Bruce - Deputy Director of Nursing Standards and Safety Sussex PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF INFLUENZA VACCINE BY REGISTERED NURSES (PEER VACCINATORS) TO STAFF WORKING FOR SUSSEX PARTNERSHIP NHS FOUNDATION TRUST Version Number: 02 Patient

More information

Patient Group Direction for Rotavirus vaccine Version: ROTAVIRUS (Rotarix ) Start Date: 1 st July 2013 Expiry Date:30 th June 2015

Patient Group Direction for Rotavirus vaccine Version: ROTAVIRUS (Rotarix ) Start Date: 1 st July 2013 Expiry Date:30 th June 2015 Patient Group Direction for Rotavirus vaccine Version: ROTAVIRUS-2013. 1 (Rotarix ) Start 1 st July 2013 Expiry 30 th June 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:

More information

Consultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off

Consultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off Policy For The Adjustment Of Insulin Injections By Paediatric Diabetes Specialist Nurses/Community Paediatric Nurses Diabetes Working With Children Within NHS Grampian Co-ordinators: Lead Paediatric Diabetes

More information

THE RESPONSIBLE PHARMACIST REGULATIONS

THE RESPONSIBLE PHARMACIST REGULATIONS THE RESPONSIBLE PHARMACIST REGULATIONS A SUMMARY OF THE RESPONSES TO PUBLIC CONSULTATION ON PROPOSALS FOR THE CONTENT OF THE REGULATIONS DH INFORMATION READER BOX Policy HR / Workforce Management Planning

More information

PATIENT GROUP DIRECTIONS POLICY

PATIENT GROUP DIRECTIONS POLICY PATIENT GROUP DIRECTIONS POLICY To be read in conjunction with the Medicines Policy and the Controlled Drugs Policy Version: 5 Ratified by: Senior Managers Operations Group Date ratified: August 2015 October

More information

Background Rationale for resource

Background Rationale for resource Slide 1 Background The Joint Committee on Vaccination and Immunisation 1 reviewed all the available medical, epidemiological and economic evidence as well as vaccine safety and efficacy relevant to offering

More information

28 th September Author Jeremy Gilbert Bariatric Nurse Specialist

28 th September Author Jeremy Gilbert Bariatric Nurse Specialist POLICY FOR SELF ADMINISTRATION OF CONTINUOUS POSITIVE AIRWAY PRESSURE BY COMPETENT PATIENTS COMING IN FOR METABOLIC AND OBESITY SURGERY (BARIATRIC SURGERY) TO PENDENNIS WARD 28 th September 2014 Author

More information

Patient Group Direction for the Supply of Nitrofurantoin MR 100mg capsules

Patient Group Direction for the Supply of Nitrofurantoin MR 100mg capsules October 2016 Patient Group Direction for the Supply of Nitrofurantoin MR 100mg capsules This Patient Group Direction (PGD) is a specific written instruction for the supply and/or administration of nitrofurantoin

More information

Administration of Tuberculin Purified Protein Derivative (PPD) 2TU per 0.1ml to patients attending BCG clinics with identified TB at risk factors.

Administration of Tuberculin Purified Protein Derivative (PPD) 2TU per 0.1ml to patients attending BCG clinics with identified TB at risk factors. Administration of Tuberculin Purified Protein Derivative (PPD) 2TU per 0.1ml to patients attending BCG clinics with identified TB at risk factors. Special notes PPD is an unlicensed medicine and therefore

More information

Background Rationale of resource Please note:

Background Rationale of resource Please note: Background In 2010, the Joint Committee on Vaccination and Immunisation (JCVI) convened a meningococcal subcommittee to conduct a comprehensive and detailed assessment of the evidence on the meningococcal

More information